Acquisition of the constitutively active Janus kinase 2 (JAK2 ... and phosphotidylinositol 3-kinase (PI3K) signalling pathways, and transforms haematopoietic progenitors. The identification ...
Janus kinase (JAK) inhibitors are an important treatment option for people with chronic inflammatory diseases such as ...
News-Medical.Net on MSN12d
Experts release new guidelines on JAK inhibitors for chronic inflammatory diseasesJanus kinase inhibitors (JAKis) are an important treatment option for people with chronic inflammatory diseases such as rheumatoid arthritis, psoriasis, Crohn's disease or ulcerative colitis.
Dizal announces new findings on golidocitinib; to present clinical results at ELCC 2025 in Paris on March 26-29: Shanghai Saturday, March 22, 2025, 17:00 Hrs [IST] Dizal, a biopha ...
Dizal (SSE: 688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback